Literature DB >> 681330

Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.

B Osterud, B N Bouma, J H Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 681330

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  19 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

Authors:  Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh
Journal:  J Biochem       Date:  2010-07-20       Impact factor: 3.387

Review 3.  Recent Insights Into the Regulation of Coagulation and Thrombosis.

Authors:  Xian Li; Martha M S Sim; Jeremy P Wood
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-22       Impact factor: 8.311

4.  Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.

Authors:  Taketoshi Ogawa; Ingrid M Verhamme; Mao-Fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2005-04-13       Impact factor: 5.157

5.  Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Authors:  Mari I Jonsson; Annasara E Lenman; Lars Frängsmyr; Cecilia Nyberg; Mohamed Abdullahi; Niklas Arnberg
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

6.  Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.

Authors:  C Puy; E I Tucker; Z C Wong; D Gailani; S A Smith; S H Choi; J H Morrissey; A Gruber; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-07       Impact factor: 5.824

7.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

8.  A galactopoiesis accordant yield of functional recombinant human factor IX from homozygous transgenic pigs requires a large amount of vitamin K supplementation.

Authors:  Chon-Ho Yen; Tien-Shuh Yang; Yin-Shen Lin; Meng-Hwan Lee; Kuo-Cheng Yu; Chung-Lin Huang; How-Hong Hsieh; Ching-Fu Tu
Journal:  Transgenic Res       Date:  2016-05-09       Impact factor: 2.788

9.  Cleavage and inactivation of Factor IX by granulocyte elastase.

Authors:  A Takaki; D L Enfield; A R Thompson
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

Authors:  D Zhong; K J Smith; J J Birktoft; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.